Summary
Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients
At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test.
According to APO Research, The global Fungal Infection Diagnosis market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Fungal Infection Diagnosis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Fungal Infection Diagnosis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Fungal Infection Diagnosis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Fungal Infection Diagnosis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Fungal Infection Diagnosis include ASSOCIATES OF CAPE COD, BioRad, IMMY, Beijing Jinshanchuan, Danna Biological and Zhanjiang A & C Biological Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Fungal Infection Diagnosis, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Fungal Infection Diagnosis, also provides the revenue of main regions and countries. Of the upcoming market potential for Fungal Infection Diagnosis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Fungal Infection Diagnosis revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Fungal Infection Diagnosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Fungal Infection Diagnosis revenue, projected growth trends, production technology, application and end-user industry.
Fungal Infection Diagnosis segment by Company
ASSOCIATES OF CAPE COD
BioRad
IMMY
Beijing Jinshanchuan
Danna Biological
Zhanjiang A & C Biological Ltd.
Fungal Infection Diagnosis segment by Type
Galactomannan Test
(1 to 3)-β-D-glucan Experiment
Fungal Infection Diagnosis segment by Application
Hospital
Laboratory
Others
Fungal Infection Diagnosis segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fungal Infection Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fungal Infection Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fungal Infection Diagnosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Fungal Infection Diagnosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Fungal Infection Diagnosis company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fungal Infection Diagnosis revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Fungal Infection Diagnosis Market by Type
1.2.1 Global Fungal Infection Diagnosis Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Galactomannan Test
1.2.3 (1 to 3)-β-D-glucan Experiment
1.3 Fungal Infection Diagnosis Market by Application
1.3.1 Global Fungal Infection Diagnosis Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Fungal Infection Diagnosis Market Dynamics
2.1 Fungal Infection Diagnosis Industry Trends
2.2 Fungal Infection Diagnosis Industry Drivers
2.3 Fungal Infection Diagnosis Industry Opportunities and Challenges
2.4 Fungal Infection Diagnosis Industry Restraints
3 Global Growth Perspective
3.1 Global Fungal Infection Diagnosis Market Perspective (2019-2030)
3.2 Global Fungal Infection Diagnosis Growth Trends by Region
3.2.1 Global Fungal Infection Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Fungal Infection Diagnosis Market Size by Region (2019-2024)
3.2.3 Global Fungal Infection Diagnosis Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Fungal Infection Diagnosis Revenue by Players
4.1.1 Global Fungal Infection Diagnosis Revenue by Players (2019-2024)
4.1.2 Global Fungal Infection Diagnosis Revenue Market Share by Players (2019-2024)
4.1.3 Global Fungal Infection Diagnosis Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Fungal Infection Diagnosis Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Fungal Infection Diagnosis Key Players Headquarters & Area Served
4.4 Global Fungal Infection Diagnosis Players, Product Type & Application
4.5 Global Fungal Infection Diagnosis Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Fungal Infection Diagnosis Market CR5 and HHI
4.6.2 Global Top 5 and 10 Fungal Infection Diagnosis Players Market Share by Revenue in 2023
4.6.3 2023 Fungal Infection Diagnosis Tier 1, Tier 2, and Tier 3
5 Fungal Infection Diagnosis Market Size by Type
5.1 Global Fungal Infection Diagnosis Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Fungal Infection Diagnosis Revenue by Type (2019-2030)
5.3 Global Fungal Infection Diagnosis Revenue Market Share by Type (2019-2030)
6 Fungal Infection Diagnosis Market Size by Application
6.1 Global Fungal Infection Diagnosis Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Fungal Infection Diagnosis Revenue by Application (2019-2030)
6.3 Global Fungal Infection Diagnosis Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 ASSOCIATES OF CAPE COD
7.1.1 ASSOCIATES OF CAPE COD Comapny Information
7.1.2 ASSOCIATES OF CAPE COD Business Overview
7.1.3 ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Revenue and Gross Margin (2019-2024)
7.1.4 ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Product Portfolio
7.1.5 ASSOCIATES OF CAPE COD Recent Developments
7.2 BioRad
7.2.1 BioRad Comapny Information
7.2.2 BioRad Business Overview
7.2.3 BioRad Fungal Infection Diagnosis Revenue and Gross Margin (2019-2024)
7.2.4 BioRad Fungal Infection Diagnosis Product Portfolio
7.2.5 BioRad Recent Developments
7.3 IMMY
7.3.1 IMMY Comapny Information
7.3.2 IMMY Business Overview
7.3.3 IMMY Fungal Infection Diagnosis Revenue and Gross Margin (2019-2024)
7.3.4 IMMY Fungal Infection Diagnosis Product Portfolio
7.3.5 IMMY Recent Developments
7.4 Beijing Jinshanchuan
7.4.1 Beijing Jinshanchuan Comapny Information
7.4.2 Beijing Jinshanchuan Business Overview
7.4.3 Beijing Jinshanchuan Fungal Infection Diagnosis Revenue and Gross Margin (2019-2024)
7.4.4 Beijing Jinshanchuan Fungal Infection Diagnosis Product Portfolio
7.4.5 Beijing Jinshanchuan Recent Developments
7.5 Danna Biological
7.5.1 Danna Biological Comapny Information
7.5.2 Danna Biological Business Overview
7.5.3 Danna Biological Fungal Infection Diagnosis Revenue and Gross Margin (2019-2024)
7.5.4 Danna Biological Fungal Infection Diagnosis Product Portfolio
7.5.5 Danna Biological Recent Developments
7.6 Zhanjiang A & C Biological Ltd.
7.6.1 Zhanjiang A & C Biological Ltd. Comapny Information
7.6.2 Zhanjiang A & C Biological Ltd. Business Overview
7.6.3 Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Revenue and Gross Margin (2019-2024)
7.6.4 Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Product Portfolio
7.6.5 Zhanjiang A & C Biological Ltd. Recent Developments
8 North America
8.1 North America Fungal Infection Diagnosis Revenue (2019-2030)
8.2 North America Fungal Infection Diagnosis Revenue by Type (2019-2030)
8.2.1 North America Fungal Infection Diagnosis Revenue by Type (2019-2024)
8.2.2 North America Fungal Infection Diagnosis Revenue by Type (2025-2030)
8.3 North America Fungal Infection Diagnosis Revenue Share by Type (2019-2030)
8.4 North America Fungal Infection Diagnosis Revenue by Application (2019-2030)
8.4.1 North America Fungal Infection Diagnosis Revenue by Application (2019-2024)
8.4.2 North America Fungal Infection Diagnosis Revenue by Application (2025-2030)
8.5 North America Fungal Infection Diagnosis Revenue Share by Application (2019-2030)
8.6 North America Fungal Infection Diagnosis Revenue by Country
8.6.1 North America Fungal Infection Diagnosis Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Fungal Infection Diagnosis Revenue by Country (2019-2024)
8.6.3 North America Fungal Infection Diagnosis Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Fungal Infection Diagnosis Revenue (2019-2030)
9.2 Europe Fungal Infection Diagnosis Revenue by Type (2019-2030)
9.2.1 Europe Fungal Infection Diagnosis Revenue by Type (2019-2024)
9.2.2 Europe Fungal Infection Diagnosis Revenue by Type (2025-2030)
9.3 Europe Fungal Infection Diagnosis Revenue Share by Type (2019-2030)
9.4 Europe Fungal Infection Diagnosis Revenue by Application (2019-2030)
9.4.1 Europe Fungal Infection Diagnosis Revenue by Application (2019-2024)
9.4.2 Europe Fungal Infection Diagnosis Revenue by Application (2025-2030)
9.5 Europe Fungal Infection Diagnosis Revenue Share by Application (2019-2030)
9.6 Europe Fungal Infection Diagnosis Revenue by Country
9.6.1 Europe Fungal Infection Diagnosis Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Fungal Infection Diagnosis Revenue by Country (2019-2024)
9.6.3 Europe Fungal Infection Diagnosis Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Fungal Infection Diagnosis Revenue (2019-2030)
10.2 China Fungal Infection Diagnosis Revenue by Type (2019-2030)
10.2.1 China Fungal Infection Diagnosis Revenue by Type (2019-2024)
10.2.2 China Fungal Infection Diagnosis Revenue by Type (2025-2030)
10.3 China Fungal Infection Diagnosis Revenue Share by Type (2019-2030)
10.4 China Fungal Infection Diagnosis Revenue by Application (2019-2030)
10.4.1 China Fungal Infection Diagnosis Revenue by Application (2019-2024)
10.4.2 China Fungal Infection Diagnosis Revenue by Application (2025-2030)
10.5 China Fungal Infection Diagnosis Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Fungal Infection Diagnosis Revenue (2019-2030)
11.2 Asia Fungal Infection Diagnosis Revenue by Type (2019-2030)
11.2.1 Asia Fungal Infection Diagnosis Revenue by Type (2019-2024)
11.2.2 Asia Fungal Infection Diagnosis Revenue by Type (2025-2030)
11.3 Asia Fungal Infection Diagnosis Revenue Share by Type (2019-2030)
11.4 Asia Fungal Infection Diagnosis Revenue by Application (2019-2030)
11.4.1 Asia Fungal Infection Diagnosis Revenue by Application (2019-2024)
11.4.2 Asia Fungal Infection Diagnosis Revenue by Application (2025-2030)
11.5 Asia Fungal Infection Diagnosis Revenue Share by Application (2019-2030)
11.6 Asia Fungal Infection Diagnosis Revenue by Country
11.6.1 Asia Fungal Infection Diagnosis Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Fungal Infection Diagnosis Revenue by Country (2019-2024)
11.6.3 Asia Fungal Infection Diagnosis Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Fungal Infection Diagnosis Revenue (2019-2030)
12.2 MEALA Fungal Infection Diagnosis Revenue by Type (2019-2030)
12.2.1 MEALA Fungal Infection Diagnosis Revenue by Type (2019-2024)
12.2.2 MEALA Fungal Infection Diagnosis Revenue by Type (2025-2030)
12.3 MEALA Fungal Infection Diagnosis Revenue Share by Type (2019-2030)
12.4 MEALA Fungal Infection Diagnosis Revenue by Application (2019-2030)
12.4.1 MEALA Fungal Infection Diagnosis Revenue by Application (2019-2024)
12.4.2 MEALA Fungal Infection Diagnosis Revenue by Application (2025-2030)
12.5 MEALA Fungal Infection Diagnosis Revenue Share by Application (2019-2030)
12.6 MEALA Fungal Infection Diagnosis Revenue by Country
12.6.1 MEALA Fungal Infection Diagnosis Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Fungal Infection Diagnosis Revenue by Country (2019-2024)
12.6.3 MEALA Fungal Infection Diagnosis Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Fungal Infection Diagnosis Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Galactomannan Test Major Manufacturers
Table 2. (1 to 3)-β-D-glucan Experiment Major Manufacturers
Table 3. Global Fungal Infection Diagnosis Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 4. Hospital Major Manufacturers
Table 5. Laboratory Major Manufacturers
Table 6. Others Major Manufacturers
Table 7. Fungal Infection Diagnosis Industry Trends
Table 8. Fungal Infection Diagnosis Industry Drivers
Table 9. Fungal Infection Diagnosis Industry Opportunities and Challenges
Table 10. Fungal Infection Diagnosis Industry Restraints
Table 11. Global Fungal Infection Diagnosis Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Fungal Infection Diagnosis Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Fungal Infection Diagnosis Market Share by Region (2019-2024)
Table 14. Global Fungal Infection Diagnosis Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Fungal Infection Diagnosis Market Share by Region (2025-2030)
Table 16. Global Fungal Infection Diagnosis Revenue by Players (US$ Million) & (2019-2024)
Table 17. Global Fungal Infection Diagnosis Revenue Market Share by Players (2019-2024)
Table 18. Global Fungal Infection Diagnosis Key Players Ranking, 2022 VS 2023 VS 2024
Table 19. Global Fungal Infection Diagnosis Key Players Headquarters & Area Served
Table 20. Global Fungal Infection Diagnosis Players, Product Type & Application
Table 21. Global Fungal Infection Diagnosis Players Commercialization Time
Table 22. Global Players Market Concentration Ratio (CR5 and HHI)
Table 23. Global Fungal Infection Diagnosis by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 24. Global Fungal Infection Diagnosis Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Fungal Infection Diagnosis Revenue by Type (2019-2024) & (US$ Million)
Table 26. Global Fungal Infection Diagnosis Revenue by Type (2025-2030) & (US$ Million)
Table 27. Global Fungal Infection Diagnosis Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 28. Global Fungal Infection Diagnosis Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 29. Global Fungal Infection Diagnosis Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Fungal Infection Diagnosis Revenue by Application (2019-2024) & (US$ Million)
Table 31. Global Fungal Infection Diagnosis Revenue by Application (2025-2030) & (US$ Million)
Table 32. Global Fungal Infection Diagnosis Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 33. Global Fungal Infection Diagnosis Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 34. ASSOCIATES OF CAPE COD Company Information
Table 35. ASSOCIATES OF CAPE COD Business Overview
Table 36. ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 37. ASSOCIATES OF CAPE COD Fungal Infection Diagnosis Product Portfolio
Table 38. ASSOCIATES OF CAPE COD Recent Development
Table 39. BioRad Company Information
Table 40. BioRad Business Overview
Table 41. BioRad Fungal Infection Diagnosis Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 42. BioRad Fungal Infection Diagnosis Product Portfolio
Table 43. BioRad Recent Development
Table 44. IMMY Company Information
Table 45. IMMY Business Overview
Table 46. IMMY Fungal Infection Diagnosis Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 47. IMMY Fungal Infection Diagnosis Product Portfolio
Table 48. IMMY Recent Development
Table 49. Beijing Jinshanchuan Company Information
Table 50. Beijing Jinshanchuan Business Overview
Table 51. Beijing Jinshanchuan Fungal Infection Diagnosis Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 52. Beijing Jinshanchuan Fungal Infection Diagnosis Product Portfolio
Table 53. Beijing Jinshanchuan Recent Development
Table 54. Danna Biological Company Information
Table 55. Danna Biological Business Overview
Table 56. Danna Biological Fungal Infection Diagnosis Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 57. Danna Biological Fungal Infection Diagnosis Product Portfolio
Table 58. Danna Biological Recent Development
Table 59. Zhanjiang A & C Biological Ltd. Company Information
Table 60. Zhanjiang A & C Biological Ltd. Business Overview
Table 61. Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 62. Zhanjiang A & C Biological Ltd. Fungal Infection Diagnosis Product Portfolio
Table 63. Zhanjiang A & C Biological Ltd. Recent Development
Table 64. North America Fungal Infection Diagnosis Revenue by Type (2019-2024) & (US$ Million)
Table 65. North America Fungal Infection Diagnosis Revenue by Application (2019-2024) & (US$ Million)
Table 66. North America Fungal Infection Diagnosis Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 67. North America Fungal Infection Diagnosis Revenue by Country (2019-2024) & (US$ Million)
Table 68. North America Fungal Infection Diagnosis Revenue by Country (2025-2030) & (US$ Million)
Table 69. Europe Fungal Infection Diagnosis Revenue by Type (2019-2024) & (US$ Million)
Table 70. Europe Fungal Infection Diagnosis Revenue by Application (2019-2024) & (US$ Million)
Table 71. Europe Fungal Infection Diagnosis Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 72. Europe Fungal Infection Diagnosis Revenue by Country (2019-2024) & (US$ Million)
Table 73. Europe Fungal Infection Diagnosis Revenue by Country (2025-2030) & (US$ Million)
Table 74. China Fungal Infection Diagnosis Revenue by Type (2019-2024) & (US$ Million)
Table 75. China Fungal Infection Diagnosis Revenue by Application (2019-2024) & (US$ Million)
Table 76. Asia Fungal Infection Diagnosis Revenue by Type (2019-2024) & (US$ Million)
Table 77. Asia Fungal Infection Diagnosis Revenue by Application (2019-2024) & (US$ Million)
Table 78. Asia Fungal Infection Diagnosis Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 79. Asia Fungal Infection Diagnosis Revenue by Country (2019-2024) & (US$ Million)
Table 80. Asia Fungal Infection Diagnosis Revenue by Country (2025-2030) & (US$ Million)
Table 81. MEALA Fungal Infection Diagnosis Revenue by Type (2019-2024) & (US$ Million)
Table 82. MEALA Fungal Infection Diagnosis Revenue by Application (2019-2024) & (US$ Million)
Table 83. MEALA Fungal Infection Diagnosis Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 84. MEALA Fungal Infection Diagnosis Revenue by Country (2019-2024) & (US$ Million)
Table 85. MEALA Fungal Infection Diagnosis Revenue by Country (2025-2030) & (US$ Million)
Table 86. Research Programs/Design for This Report
Table 87. Authors List of This Report
Table 88. Secondary Sources
Table 89. Primary Sources
List of Figures
Figure 1. Fungal Infection Diagnosis Product Picture
Figure 2. Global Fungal Infection Diagnosis Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Fungal Infection Diagnosis Market Size Share 2019 VS 2023 VS 2030
Figure 4. Galactomannan Test Picture
Figure 5. (1 to 3)-β-D-glucan Experiment Picture
Figure 6. Global Fungal Infection Diagnosis Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Fungal Infection Diagnosis Market Size Share 2019 VS 2023 VS 2030
Figure 8. Hospital Picture
Figure 9. Laboratory Picture
Figure 10. Others Picture
Figure 11. Global Fungal Infection Diagnosis Market Size (US$ Million) & (2019-2030)
Figure 12. Global Fungal Infection Diagnosis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Fungal Infection Diagnosis Market Share by Region: 2019 VS 2023 VS 2030
Figure 14. Global Fungal Infection Diagnosis Players Revenue Share Top 10 and Top 5 in 2023
Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 16. Global Fungal Infection Diagnosis Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Fungal Infection Diagnosis Revenue Market Share 2019 VS 2023 VS 2030
Figure 18. Global Fungal Infection Diagnosis Revenue Market Share by Type (2019-2030)
Figure 19. Global Fungal Infection Diagnosis Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Fungal Infection Diagnosis Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 21. Global Fungal Infection Diagnosis Revenue Market Share by Application (2019-2030)
Figure 22. North America Fungal Infection Diagnosis Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Fungal Infection Diagnosis Revenue by Type (2025-2030) & (US$ Million)
Figure 24. North America Fungal Infection Diagnosis Revenue Share by Type (2019-2030)
Figure 25. North America Fungal Infection Diagnosis Revenue by Application (2025-2030) & (US$ Million)
Figure 26. North America Fungal Infection Diagnosis Revenue Share by Application (2019-2030)
Figure 27. North America Fungal Infection Diagnosis Revenue Share by Country (2019-2030)
Figure 28. United States Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Canada Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Europe Fungal Infection Diagnosis Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Fungal Infection Diagnosis Revenue by Type (2025-2030) & (US$ Million)
Figure 32. Europe Fungal Infection Diagnosis Revenue Share by Type (2019-2030)
Figure 33. Europe Fungal Infection Diagnosis Revenue by Application (2025-2030) & (US$ Million)
Figure 34. Europe Fungal Infection Diagnosis Revenue Share by Application (2019-2030)
Figure 35. Europe Fungal Infection Diagnosis Revenue Share by Country (2019-2030)
Figure 36. Germany Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. France Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. U.K. Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Italy Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Russia Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Nordic Countries Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. China Fungal Infection Diagnosis Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Fungal Infection Diagnosis Revenue by Type (2025-2030) & (US$ Million)
Figure 44. China Fungal Infection Diagnosis Revenue Share by Type (2019-2030)
Figure 45. China Fungal Infection Diagnosis Revenue by Application (2025-2030) & (US$ Million)
Figure 46. China Fungal Infection Diagnosis Revenue Share by Application (2019-2030)
Figure 47. Asia Fungal Infection Diagnosis Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 48. Asia Fungal Infection Diagnosis Revenue by Type (2025-2030) & (US$ Million)
Figure 49. Asia Fungal Infection Diagnosis Revenue Share by Type (2019-2030)
Figure 50. Asia Fungal Infection Diagnosis Revenue by Application (2025-2030) & (US$ Million)
Figure 51. Asia Fungal Infection Diagnosis Revenue Share by Application (2019-2030)
Figure 52. Asia Fungal Infection Diagnosis Revenue Share by Country (2019-2030)
Figure 53. Japan Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. South Korea Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. India Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. Australia Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. China Taiwan Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Southeast Asia Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. MEALA Fungal Infection Diagnosis Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 60. MEALA Fungal Infection Diagnosis Revenue by Type (2025-2030) & (US$ Million)
Figure 61. MEALA Fungal Infection Diagnosis Revenue Share by Type (2019-2030)
Figure 62. MEALA Fungal Infection Diagnosis Revenue by Application (2025-2030) & (US$ Million)
Figure 63. MEALA Fungal Infection Diagnosis Revenue Share by Application (2019-2030)
Figure 64. MEALA Fungal Infection Diagnosis Revenue Share by Country (2019-2030)
Figure 65. Mexico Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. South Korea Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Brazil Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Israel Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Argentina Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Colombia Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Turkey Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Saudi Arabia Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. UAE Fungal Infection Diagnosis Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Years Considered
Figure 75. Research Process
Figure 76. Key Executives Interviewed
